Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats

Neuroscience Letters

Volumn 280, Issue 3, 2000, Pages 211-214

  Hao, Jing Xia ^a   Xu, Xiao Jun ^a   Urban, Lászlo ^b   Wiesenfeld Hallin, Zsuzsanna ^a  

^a Div Clin Neurophysiol   (Sweden)

^b Novatis Inst for Medical Sciences   (United Kingdom)

Author keywords

Analgesia; Central pain; Neuropathic pain

Indexed keywords

GABAPENTIN;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; NEUROMODULATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY;

ACETIC ACIDS; AMINES; ANALGESICS; ANIMALS; COLD; CYCLOHEXANECARBOXYLIC ACIDS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, INTRAPERITONEAL; PAIN; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; TIME FACTORS;

EID: 0033974911     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00787-4     Document Type: Article

References (20)

1. Abdi S., Lee D.H., Chung J.M. The anti-allodynic effect of amitriptyline, gabapentin and lidocaine in a rat model of neuropathic pain. Anesth. Analg. 87:1998;1360-1366.
2. Attal N., Brasseur L., Parker F., Chauvin M., Bouhassira D. Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study. Exp. Neurol. 40:1998;191-200.
3. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. J. Am. Med. Assoc. 280:1990;1831-1836.
4. Bryans J.S., Davies N., Gee N.S., Dissannavake V.U., Ratcliffe G.S., Horwell D.C., Kneen C.O., Morrell A.I., Oles R.J., O'Toole J.C., Perkins G.M., Singh L., Suman-Chauhan N., O'Neill J.A. Identification of novel ligands for the gabapentin binding site on the alpha2 delta subunits of a calcium channel and their evaluation as anticonvulsant agents. J. Med. Chem. 41:1998;1838-1845.
5. Field M.J., Oles R.J., Lewis A.S., McCleary S., Hughes J., Singh L. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br. J. Pharmacol. 121:1997;1513-1522.
6. Gillin S., Sorkin L.S. Gabapentin reverses the allodynia produced by the administration of anti-GD2 ganglioside, an immunotherapeutic drug. Anesth. Analg. 86:1998;111-116.
7. Hao J.-X., Xu X.-J. Treatment of a chronic allodynia-like response in spinally injured rats: Effects of systemically administered excitatory amino acid receptor antagonists. Pain. 66:1996;279-285.
8. Hunter J.C., Gogas K.R., Hedley L.R., Jacobson L.O., Kassotakis L., Thompson I., Fontana D.J. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. J. Pharmacol. 324:1997;153-160.
9. Pan H.L., Eisenach J.C., Chen S.R. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J. Pharmacol. Exp. Ther. 288:1999;1026-1030.
10. Radulovic L.L., Turck D., von Hodenberg A., Vollmer K.O., McNally W.P., DeHart P.D., Hanson B.J., Bockbrader H.N., Chang T. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys. Drug Metab. Dispos. 23:1995;441-448.
11. Rosenberg J.M., Harrell C., Ristic H., Werner R.A., De Rosayro A.M. The effect of gabapentin on neuropathic pain. Clin. J. Pain. 13:1997;251-255.
12. Rosner H., Rubin L., Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin. J. Pain. 12:1996;56-58.
13. Rowbotham M., Harden N., Stacey B., Bernstein P., Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. J. Am. Med. Assoc. 280:1998;1837-1842.
14. Singh L., Field M.J., Ferris P., Hunter J.C., Oles R.J., Williams R.G., Woodruff J.C. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by d-serine. Psychopharmacology. 127:1996;1-9.
15. Stanfa L.C., Singh L., Williams R.G., Dickenson A.H. Gabapentin, ineffective in normal rats, markedly reduces C-fibre evoked responses after inflammation. NeuroReport. 8:1997;587-590.
16. Stefani A., Spadoni F., Bernardi G. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology. 37:1998;83-91.
17. Taylor C.P., Gee N.S., Su T.Z., Kocsis J.D., Welty D.F., Brown J.P., Dooley D.J., Boden P., Singh L. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29:1998;233-249.
18. Vollmer K.O., von Hodenberg A., Kolle E.U. Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittel-Forschung. 36:1986;830-839.
19. Welty D.F., Schielke G.P., Vartanian M.G., Taylor C.P. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate. Epilepsy Res. 16:1993;175-181.
20. Xu X.-J., Hao J.-X., Aldskogius H., Seiger Å., Wiesenfeld-Hallin Z. Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Pain. 48:1992;279-290.